← Back to guidelines
Palliative Care7 papers

Abnormal communication between pericardial sac and pleura

Last edited:

Overview

Abnormal communication between the pericardial sac and the pleura, often referred to as a diaphragmatic hernia or a pericardiopulmonary fistula, is a rare but serious condition that can arise from various underlying pathologies such as malignancy, infection, or post-surgical complications. This condition can lead to significant hemodynamic instability due to fluid shifts and impaired respiratory function. Early recognition and comprehensive management are crucial for improving patient outcomes and aligning care with patient values and preferences, particularly in palliative settings. The evidence suggests that proactive communication about serious illness significantly enhances patient care and satisfaction, highlighting the importance of integrating palliative care principles early in the management process [PMID:30870556].

Clinical Presentation

Patients with abnormal communication between the pericardial sac and pleura often present with a constellation of symptoms that reflect both cardiac and respiratory compromise. Common clinical manifestations include dyspnea, chest pain, and signs of hemodynamic instability such as hypotension and tachycardia. These symptoms can be exacerbated by positional changes, particularly when lying down, due to fluid shifts across the abnormal communication. Additionally, patients may exhibit signs of pleural effusion or pericardial effusion, which can be detected through physical examination and imaging studies like chest X-rays and echocardiography. The timing of recognizing these symptoms is critical, as early intervention can mitigate severe complications. Notably, intervention patients reported initiating conversations about serious illness a median 2.4 months earlier than controls (143 days vs 71 days), underscoring the importance of early identification and proactive communication in managing expectations and care preferences [PMID:30870556]. This early engagement aligns with palliative care principles, ensuring that patients and their families are well-informed and prepared for potential outcomes, thereby improving overall quality of life and satisfaction with care.

Diagnosis

Diagnosing abnormal communication between the pericardial sac and pleura requires a multi-faceted approach combining clinical suspicion with advanced diagnostic tools. Initial clinical suspicion often arises from the aforementioned symptoms and signs of hemodynamic instability. Imaging plays a pivotal role in confirming the diagnosis. Chest X-rays may reveal abnormalities such as pleural effusions or changes indicative of diaphragmatic herniation. Echocardiography is particularly valuable, as it can detect pericardial effusions and sometimes visualize the abnormal connection between the pericardium and pleura. Contrast-enhanced CT scans provide detailed anatomical information, often revealing the extent and nature of the communication. In some cases, MRI may be utilized for further characterization, especially when soft tissue involvement is suspected. Diagnostic paracentesis or pericardiocentesis, guided by imaging, can also be crucial, not only for fluid analysis but also for ruling out infectious or neoplastic etiologies contributing to the communication [PMID:30870556]. Early and accurate diagnosis is essential for timely intervention and appropriate management planning.

Management

The management of abnormal communication between the pericardial sac and pleura is multifaceted, focusing on both immediate stabilization and long-term palliation, depending on the underlying cause and patient prognosis. Immediate stabilization often involves addressing hemodynamic instability through fluid resuscitation, inotropic support, and sometimes mechanical ventilation if respiratory compromise is significant. In cases where infection is suspected or confirmed, targeted antibiotic therapy is essential. For neoplastic etiologies, oncologic management strategies, including chemotherapy or radiation therapy, may be necessary, tailored to the patient's overall condition and preferences. Surgical intervention might be required in certain scenarios, particularly if there is a large, symptomatic communication that cannot be managed conservatively. Endovascular approaches, such as embolization or stent placement, may offer less invasive alternatives in selected cases.

A critical component of management is the integration of palliative care principles, as evidenced by the Serious Illness Care Program. This program demonstrated that intervention patients had a higher proportion (96% vs 79%) engaging in documented serious illness conversations, which were more comprehensive and patient-centered [PMID:30870556]. These conversations focused on values, goals, prognosis, and treatment preferences, significantly enhancing palliative care management. Such proactive communication not only improves patient understanding and satisfaction but also ensures that care aligns with individual patient needs and wishes, particularly important in managing chronic or terminal conditions. Ensuring accessibility of these conversations in the electronic medical record (EMR) supports better continuity and coordination of follow-up care, facilitating smoother transitions and comprehensive care planning [PMID:30870556].

Prognosis & Follow-up

The prognosis for patients with abnormal communication between the pericardial sac and pleura varies widely depending on the underlying cause, the extent of the communication, and the patient's overall health status. In cases where the communication is due to benign causes or effectively managed with timely intervention, outcomes can be favorable. However, when malignancy or severe infection underlies the condition, the prognosis may be guarded, often necessitating a palliative care approach focused on symptom management and quality of life improvement. Regular follow-up is essential to monitor for recurrence of symptoms, complications, and to reassess treatment efficacy and patient preferences over time. The documented accessibility of serious illness conversations in the EMR (61% vs 11% in intervention vs control groups) significantly supports better continuity of care [PMID:30870556]. This documentation ensures that healthcare providers have a clear understanding of patient values and goals, facilitating more personalized and coordinated follow-up care. Regular reassessment and communication with patients and families about evolving treatment options and prognosis are crucial for maintaining alignment with patient-centered care objectives.

Key Recommendations

  • Early Recognition and Communication: Promptly recognize symptoms indicative of pericardiopulmonary communication and initiate early conversations about serious illness to align care with patient preferences and values [PMID:30870556].
  • Comprehensive Diagnostic Workup: Utilize a combination of clinical assessment, imaging (chest X-ray, echocardiography, CT, MRI), and diagnostic procedures (paracentesis, pericardiocentesis) to accurately diagnose the condition [PMID:30870556].
  • Multidisciplinary Management: Employ a multidisciplinary approach involving cardiologists, pulmonologists, surgeons, and palliative care specialists to address both acute stabilization and long-term management needs [PMID:30870556].
  • Documentation and Coordination: Ensure thorough documentation of serious illness conversations in the EMR to support continuity of care and facilitate coordinated follow-up management [PMID:30870556].
  • Patient-Centered Care: Focus on comprehensive, patient-centered discussions regarding prognosis, treatment options, and goals of care to enhance patient satisfaction and quality of life [PMID:30870556].
  • References

    1 Paladino J, Bernacki R, Neville BA, Kavanagh J, Miranda SP, Palmor M et al.. Evaluating an Intervention to Improve Communication Between Oncology Clinicians and Patients With Life-Limiting Cancer: A Cluster Randomized Clinical Trial of the Serious Illness Care Program. JAMA oncology 2019. link

    1 papers cited of 7 indexed.

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG